当前位置:首页 - 行情中心 - 生物股份(600201) - 财务分析 - 现金流量表

生物股份

(600201)

  

流通市值:94.61亿  总市值:94.61亿
流通股本:11.12亿   总股本:11.12亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金626,752,403.92297,554,658.331,318,502,472.36936,112,261.55
  收到其他与经营活动有关的现金68,051,888.36,181,897.199,756,534.9673,104,189.96
  经营活动现金流入小计694,804,292.22303,736,555.431,418,259,007.321,009,216,451.51
  购买商品、接受劳务支付的现金223,183,370.78115,881,816.17283,644,422.14277,479,887.4
  支付给职工以及为职工支付的现金124,768,272.774,071,212.02247,408,993.95180,644,473.11
  支付的各项税费55,072,186.1916,626,521.297,752,734.6881,354,513.13
  支付其他与经营活动有关的现金202,837,118.9670,938,608.05499,900,642.45258,459,300.6
  经营活动现金流出小计605,860,948.63277,518,157.441,128,706,793.22797,938,174.24
  经营活动产生的现金流量净额88,943,343.5926,218,397.99289,552,214.1211,278,277.27
二、投资活动产生的现金流量:
  收回投资收到的现金155,877,998.28-10,500,00010,500,000
  取得投资收益收到的现金6,706,070.363,041,540.3844,236,208.0928,261,697.72
  处置固定资产、无形资产和其他长期资产收回的现金净额17,766.9910,000844,765.77793,977.06
  收到的其他与投资活动有关的现金66,125,634.9610,000,000684,203,299.67333,684,832.05
  投资活动现金流入小计228,727,470.5913,051,540.38739,784,273.53373,240,506.83
  购建固定资产、无形资产和其他长期资产支付的现金30,678,394.5511,340,579.7789,666,302.7864,131,907.6
  投资支付的现金16,000,00016,000,0004,000,0004,456,806.05
  支付其他与投资活动有关的现金70,000,00040,000,0001,099,264,149.17602,315,038.06
  投资活动现金流出小计116,678,394.5567,340,579.771,192,930,451.95670,903,751.71
  投资活动产生的现金流量净额112,049,076.04-54,289,039.39-453,146,178.42-297,663,244.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,000,0002,000,000--
  其中:子公司吸收少数股东投资收到的现金2,000,0002,000,000--
  取得借款收到的现金--15,000,000-
  收到其他与筹资活动有关的现金3,486,6703,486,6708,251,859.727,346,106.9
  筹资活动现金流入小计5,486,6705,486,67023,251,859.727,346,106.9
  分配股利、利润或偿付利息支付的现金33,138,942.8283,37589,365,410.0889,202,716.76
  支付其他与筹资活动有关的现金228,706,528.2499,889,697.059,129,552.4614,961,964.7
  筹资活动现金流出小计261,845,471.0699,973,072.0598,494,962.54104,164,681.46
  筹资活动产生的现金流量净额-256,358,801.06-94,486,402.05-75,243,102.82-96,818,574.56
四、汇率变动对现金及现金等价物的影响--1,272.4519,577.62
五、现金及现金等价物净增加额-55,366,381.43-122,557,043.45-238,835,794.69-183,183,964.55
  加:期初现金及现金等价物余额813,924,373.52820,199,434.21,052,760,168.211,052,760,168.21
  期末现金及现金等价物余额758,557,992.09697,642,390.75813,924,373.52869,576,203.66
补充资料:
  净利润58,675,416.45-104,154,092.64-
  资产减值准备4,373,994.18-31,072,325.92-
  固定资产和投资性房地产折旧76,728,164.53-151,298,564.93-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧76,728,164.53---
  无形资产摊销52,667,403.43-63,880,823.47-
  长期待摊费用摊销855,950.91-1,349,681.42-
  处置固定资产、无形资产和其他长期资产的损失51,912.84--2,575,161.17-
  固定资产报废损失250,829.84-1,093,085.96-
  公允价值变动损失110,945.37--2,815,245.68-
  财务费用-22,000,409.94--43,997,628.34-
  投资损失-15,045,803.24-12,301,592.56-
  递延所得税633,475.26-500,663.54-
  其中:递延所得税资产减少1,455,250.93--854,377.16-
    递延所得税负债增加-821,775.67-1,355,040.7-
  存货的减少-2,622,302.31-14,253,854.53-
  经营性应收项目的减少4,665,582.31-14,988,802.91-
  经营性应付项目的增加-71,741,473.61--83,778,586.31-
  不涉及现金收支的投资和筹资活动金额其他项目0-0-
  现金的期末余额758,557,992.09-813,924,373.52-
  减:现金的期初余额813,924,373.52-1,052,760,168.21-
  现金及现金等价物的净增加额-55,366,381.43--238,835,794.69-
公告日期2025-08-202025-04-252025-04-252024-10-31
审计意见(境内)标准无保留意见
TOP↑